Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02641171 · ClinicalTrials.gov registry record
Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- 5
- Enrollment target
NCT02641171 is a clinical trial that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT02641171 was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This study evaluates the use of exhaled air analysis as tool to monitor the disease activity in Crohn's Disease (CD). This study is a validation of the previous findings. In this study the participant will be asked to donate exhaled air, blood samples and fecal samples. The breath samples will be used to measure various volatile metabolites in breath. The breath air will be next used to validate the previous findings. The blood samples will be used to define the origin of volatile metabolites in breath. Finally, the potential of exhaled breath analysis as non-invasive marker of diseases activity will be compared to established fecal calprotectin.
Interventions
- OTHER Specimen sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-10-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02641171
The ClinicalTrials.gov registry entry for NCT02641171 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Specimen sampling is the first listed.
NCT02641171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02641171 about?
NCT02641171 is a clinical study titled "Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort". This study evaluates the use of exhaled air analysis as tool to monitor the disease activity in Crohn's Disease (CD). This study is a validation of the previous findings. In this study the participant will be asked to donate exhaled air, blood samples and fecal samples. The breath samples will be us...
What is the current status of trial NCT02641171?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2015-12. Estimated completion is 2016-10-04.
What interventions are being tested in trial NCT02641171?
The interventions under investigation include: Specimen sampling (OTHER).
Who is sponsoring clinical trial NCT02641171?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.